Professor Cecilia Lindgren
Watch Cecilia's inaugural lecture "Time Flies: Spending two decades dissecting the aetiology of common complex metabolic traits" on BDI TV.
Professor of Genomic Endocrinology & Metabolism, Nuffield Department of Medicine
- Professor, Senior Group Leader Nuffield Department of Women's and Reproductive Health
- Group Head / PI and Fellow, Wellcome Trust Centre for Human Genetics
- Senior Research Fellow, St Anne's College
Obesity and its consequences are major and growing challenges for health care worldwide. Recently, the first common variants have been identified which influence overall levels of adiposity and predispose to obesity at the population level: these findings should lead to improved understanding of the mechanisms involved in the regulation of overall energy balance. However, not all obese individuals are equally vulnerable to diabetes, insulin resistance and the other adverse consequences of obesity, and it has long been appreciated that the distribution of fat (particularly the degree of central or visceral obesity) is an additional and independent determinant of individual risk of metabolic and cardiovascular disease.
Our research seeks to advance understanding of the mechanisms involved in obesity and the regulation of differential central fat accumulation in the belief that an appreciation of these mechanisms will complement advances in understanding of overall energy balance.
By applying a range of genetic and genomic approaches, we expect to identify genetic variants influencing regional fat distribution, and to illuminate some of the biological pathways involved. Our specific objectives are:
- To undertake identification of genetic variants influencing obesity and individual patterns of fat distribution and central obesity through large-scale genome-wide association meta-analysis and fine-mapping;
- To examine the relationships between sequence variation, expression of mRNA, microRNAs and molecular and physiological phenotypes, in human adipose samples, to identify adipose-specific pathways relevant to individual differences in obesity and central fat distribution;
- To follow-up of the key findings from genetic, epidemiological and functional perspectives.
This knowledge should support translational advances in the management of obesity through development of novel diagnostic and therapeutic options
Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics.
Bovijn J. et al, (2020), Science translational medicine, 12
Using human genetics to guide the repurposing of medicines.
Bovijn J. et al, (2020), International journal of epidemiology
Colocalization highlights genes in hypothalamic–pituitary–gonadal axis as potentially mediating polycystic ovary syndrome risk
Censin J. et al, (2020)
Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure.
Shah S. et al, (2020), Nat Commun, 11
Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
Day F. et al, (2019), PLoS genetics, 15